Corneal dystrophies are a group of rare hereditary disorders in which abnormal material accumulates in the cornea, the clear outer layer of the eye. These conditions cause swelling of the cornea that can lead to cloudy vision, eye discomfort, and, over the course of time — gradual and permanent vision loss.
If you have been diagnosed with a corneal dystrophy, or if your doctor has recommended a corneal transplant, you may be a candidate for Descemet membrane endothelial keratoplasty (DMEK). The procedure is an alternative to the conventional cornea transplant in which the whole thickness of the cornea is replaced. DMEK has been shown to improve visual acuity, donor cornea graft survival, and endothelial cell loss.
Are you a candidate for DMEK?
The U-M Kellogg Eye Center team will evaluate patients with corneal dystrophies to determine whether DMEK is appropriate for their condition. The procedure is approved and intended for patients with Fuchs’ corneal dystrophy, corneal edema after cataract surgery, and failed corneal transplants.
To learn more about DMEK, please schedule an appointment with the Cornea, Cataract and Refractive Surgery Clinic at 734-764-5106.